Skip to main content

MAXIMUS, INC.

For the period ended Dec 31, 2024. Filed Feb 6, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2024 · Filed Feb 6, 2025

MMS$66.12+0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Liquidity and Capital Resources

Our primary sources of liquidity are cash on hand, cash from operations, and availability under our revolving credit facilities. As of December 31, 2024, we had $72.7 million in cash and cash equivalents. We believe that our current cash position, access to our revolving debt, and cash flow generated from operations should be sufficient for our operating requirements for the next 12 months and beyond, including enabling us to fund required long-term debt repayments, dividends and any share purchases we might choose to make. See "Note 7. Debt and Derivatives" to the Consolidated Financial Statements for a more detailed discussion of our debt financing arrangements.

We have included the following table showing our debt balances as of December 31, 2024, and their effective interest rates.

Table MD&A 7: Debt Balances and Interest Rates as of December 31, 2024
December 31, 2024
Carrying valueEffective cash interest rateInterest rate basis
(dollars in thousands)
Term Loan A - Hedged through May 2026$500,0003.81%Fixed rate of 2.31% plus margin. (1)
Term Loan A - Unhedged133,7505.86%Term SOFR reset monthly plus margin. (1)
Term Loan B - Hedged through September 202675,0005.72%Fixed Rate of 3.72% plus margin. (1)
Term Loan B - Hedged through September 202575,0006.09%Fixed Rate of 4.09% plus margin. (1)
Term Loan B - Unhedged347,5006.36%Term SOFR reset monthly plus margin. (1)
Revolver270,0005.82%Term SOFR reset monthly plus margin. (1)
Debt Principal$1,401,250

(1) Applicable margins are currently 1.5% for the Term Loan A and Revolver and 2.0% for the Term Loan B. The Term Loan A and Revolver will vary based upon leverage starting in February 2025.

Our effective cash interest rate reflects the drivers of our cash interest payments as of December 31, 2024, which can change based upon the reset of the rates. Including the amortization of the upfront payments, our effective interest rate as of December 31, 2024, is 5.5%.

The below table summarizes our change in cash, cash equivalents, and restricted cash.

Table MD&A 8: Net Change in Cash and Cash Equivalents and Restricted Cash
For the Three Months Ended
December 31, 2024December 31, 2023
(in thousands)
Operating activities:
Net cash (used in)/provided by operating activities$(79,996)$21,608
Net cash used in investing activities(22,256)(20,432)
Net cash (used in)/provided by financing activities(8,257)28,382
Effect of foreign exchange rates on cash and cash equivalents and restricted cash(2,384)1,846
Net change in cash and cash equivalents and restricted cash$(112,893)$31,404

Net Cash (Used in)/Provided by Operating Activities

We reported an operating cash outflow for the first three months of fiscal year 2025, compared to cash from operations of $21.6 million in the first quarter of the 2024 fiscal year.

This outflow is consistent with slower receipts from our customers during the holiday period. Our Days Sales Outstanding ("DSO") at December 31, 2024, were 62 days, compared with 61 days at September 30, 2024.

In addition, the timing of income tax payments year-over-year has affected our operating cash flows, increasing outflows in the current fiscal year by approximately $13.0 million.

Net Cash Used in Investing Activities

We continue to make investments in our capital base, most notably in upgrading technology on our Federal MDE contracts. We anticipate the pace of this investment will decline through the latter half of fiscal year 2025.

Net Cash (Used in)/Provided by Financing Activities

We have utilized our revolving credit facility in fiscal year 2025 for working capital needs as well as purchases of Maximus common stock. During the first quarter of fiscal year 2025, we acquired 3.1 million common shares at a cost of $236.7 million. We also incurred charges from the recently-introduced excise tax on these purchases. Since December 31, 2024, we have acquired an additional 0.7 million common shares at a cost of $52.9 million, leaving approximately $85.0 million available for purchase under our existing program.

Credit Facilities

Our principal debt agreement is with JPMorgan Chase Bank N.A. (the "Credit Agreement"). At December 31, 2024, we owed $1.40 billion under the Credit Agreement, with access to an additional $480 million through a revolving credit facility. Our principal loans mature in May 2029 and May 2031, when the remaining balances must be renegotiated or repaid in full. The revolving facility also matures in May 2029. In addition, our term loans require quarterly mandatory repayments.

The Credit Agreement contains a number of covenants. Failure to meet these requirements would result in a need to renegotiate the agreement, seek a waiver, or a requirement to repay our outstanding debt in full. There are two financial covenants, both defined in the Credit Agreement:

Our Consolidated Net Total Leverage Ratio means, for any twelve-month period, the ratio of our Funded Debt (as defined by the Credit Agreement), offset by up to $150 million of unrestricted cash (Consolidated Net Total Leverage), against our Consolidated EBITDA (as defined by the Credit Agreement). To comply with our Credit Agreement, this ratio cannot exceed 4.00:1.00 at the end of each quarter, with a step up to 4.50:1.00 under certain circumstances. This ratio also determines both our interest rate and the charge we pay on the unused component of our revolving credit facility, with the charge increasing as the leverage ratio increases.

Our Consolidated Net Interest Coverage Ratio means, for any twelve-month period, the ratio of our Consolidated EBITDA against our Consolidated Net Interest Expense, as defined by the Credit Agreement. To comply with our Credit Agreement, this ratio cannot be less than 3.00:1.00 at the end of each quarter.

Consolidated EBITDA also drives certain permissions within the Credit Agreement, such as the level of investment we are entitled to make without seeking additional approval from our lenders.

Our Credit Agreement defines Consolidated EBITDA, as well as other components of the calculations above. The definition of Consolidated EBITDA requires us to include adjustments not typically included within EBITDA, including unusual, non-recurring expenses, certain non-cash adjustments, the pro forma effects of acquisitions and disposals, and estimated synergies from acquisitions. As a result, Consolidated EBITDA as defined by the Credit Agreement may not be comparable to EBITDA or related or similarly titled measures presented by other companies.

We have summarized below the components of our two financial ratio calculations, including the components of Consolidated EBITDA as defined by the Credit Agreement which are included within our financial statements. At December 31, 2024, we were in compliance with all applicable covenants of our Credit Agreement. We do not believe that these covenants represent a significant restriction on our ability to operate our business or to pay our dividends.

Table MD&A 9: Reconciliation of Net Income to Consolidated EBITDA as defined by our Credit Agreement
For the ThreeMonths EndedFor the Trailing TwelveMonths Ended
December 31, 2024December 31, 2024
(in thousands)
Net income$41,196$283,962
Adjustments:
Interest expense17,52278,455
Other expense/(income), net312(625)
Provision for income taxes27,757105,985
Amortization of intangibles23,03591,256
Stock compensation expense6,95232,874
Acquisition-related expenses1211,615
Loss on sale of businesses38,34138,341
Depreciation and amortization of property, equipment, and capitalized software8,45534,001
Pro forma and other adjustments permitted by our Credit Agreement4,05966,567
Consolidated EBITDA (as defined by our Credit Agreement)$167,750$732,431
Table MD&A 10: Consolidated Net Total Leverage Ratio
For the Trailing TwelveMonths Ended
December 31, 2024
(in thousands, except ratio data)
Funded Debt (as defined by our Credit Agreement)$1,401,250
Cash and cash equivalents up to $150 million72,653
Consolidated Net Total Leverage (as defined by our Credit Agreement)$1,328,597
Consolidated Net Total Leverage Ratio (as defined by our Credit Agreement)1.81
Table MD&A 11: Consolidated Net Interest Coverage Ratio
For the Trailing TwelveMonths Ended
December 31, 2024
(in thousands, except ratio data)
Consolidated EBITDA (as defined by our Credit Agreement)$732,431
Interest expense78,455
Components of other income/expense, net allowed in ratio calculation2,843
Consolidated Net Interest Expense (as defined by our Credit Agreement)$81,298
Consolidated Net Interest Coverage Ratio (as defined by our Credit Agreement)9.01

Cash in Foreign Locations

We have no requirement to remit funds from our foreign locations to the United States. We will continue to explore opportunities to remit additional funds, taking into consideration the working capital requirements and relevant tax rules in each jurisdiction. When we are unable to remit funds back without incurring a penalty, we will consider these funds indefinitely reinvested until such time as these restrictions are changed. As a result, we do not record U.S. deferred income taxes on any funds held in foreign jurisdictions. We have not attempted to calculate our potential liability from any transfer of these funds, as any such transaction might include tax planning strategies that we have not fully explored. Accordingly, it is not possible to estimate the potential tax obligations if we were to remit all of our funds from foreign locations to the United States.

Free Cash Flow (Non-GAAP)

Table MD&A 12: Free Cash Flow (Non-GAAP)
For the Three Months Ended
December 31, 2024December 31, 2023
(in thousands)
Net cash (used in)/provided by in operating activities$(79,996)$21,608
Purchases of property and equipment and capitalized software(22,992)(22,247)
Free cash flow (Non-GAAP)$(102,988)$(639)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.